1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe PCR Technologies Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe PCR Technologies Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Adoption of PCR Techniques
5.2 Market Opportunities
- 5.2.1 Advancements in PCR Technologies
5.3 Future Trends
- 5.3.1 Rising Investments and Funds Availability for PCR Technologies
5.4 Impact of Drivers and Restraints
6. Europe PCR Technologies Market Regional Analysis
6.1 Europe PCR Technologies Market Overview
6.2 Europe PCR Technologies Market Revenue 2020-2030 (US$ Million)
6.3 Europe PCR Technologies Market Forecast Analysis
7. Europe PCR Technologies Market Analysis – by Technology
7.1 Real-Time PCR
- 7.1.1 Overview
- 7.1.2 Real-Time PCR: Europe PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Conventional PCR
- 7.2.1 Overview
- 7.2.2 Conventional PCR: Europe PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Reverse Transcription PCR
- 7.3.1 Overview
- 7.3.2 Reverse Transcription PCR: Europe PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Digital PCR
- 7.4.1 Overview
- 7.4.2 Digital PCR: Europe PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Multiplex RT PCR
- 7.5.1 Overview
- 7.5.2 Multiplex RT PCR: Europe PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Hot Start PCR
- 7.6.1 Overview
- 7.6.2 Hot Start PCR: Europe PCR Technologies Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe PCR Technologies Market Analysis – by Offerings
8.1 Reagents & Consumables
- 8.1.1 Overview
- 8.1.2 Reagents & Consumables: Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Instruments
- 8.2.1 Overview
- 8.2.2 Instruments: Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Software & Services
- 8.3.1 Overview
- 8.3.2 Software & Services: Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe PCR Technologies Market Analysis – by End User
9.1 Hospitals & Diagnostic Centers
- 9.1.1 Overview
- 9.1.2 Software & Services: Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Academia & Research Institutes
- 9.2.1 Overview
- 9.2.2 Software & Services: Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Pharmaceutical and Biotechnology Companies
- 9.3.1 Overview
- 9.3.2 Software & Services: Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe PCR Technologies Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe PCR Technologies Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 Europe PCR Technologies Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 UK: Europe PCR Technologies Market Breakdown, by Technology
- 10.1.1.1.2 UK: Europe PCR Technologies Market Breakdown, by Offerings
- 10.1.1.1.3 UK: Europe PCR Technologies Market Breakdown, by End User
- 10.1.1.2 Germany:
Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Germany: Europe PCR Technologies Market Breakdown, by Technology
- 10.1.1.2.2 Germany: Europe PCR Technologies Market Breakdown, by Offerings
- 10.1.1.2.3 Germany: Europe PCR Technologies Market Breakdown, by End User
- 10.1.1.3 France:
Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 France: Europe PCR Technologies Market Breakdown, by Technology
- 10.1.1.3.2 France: Europe PCR Technologies Market Breakdown, by Offerings
- 10.1.1.3.3 France: Europe PCR Technologies Market Breakdown, by End User
- 10.1.1.4 Russia:
Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.4.1 Russia: Europe PCR Technologies Market Breakdown, by Technology
- 10.1.1.4.2 Russia: Europe PCR Technologies Market Breakdown, by Offerings
- 10.1.1.4.3 Russia: Europe PCR Technologies Market Breakdown, by End User
- 10.1.1.5 Italy:
Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.5.1 Italy: Europe PCR Technologies Market Breakdown, by Technology
- 10.1.1.5.2 Italy: Europe PCR Technologies Market Breakdown, by Offerings
- 10.1.1.5.3 Italy: Europe PCR Technologies Market Breakdown, by End User
- 10.1.1.6 Rest of Europe:
Europe PCR Technologies Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe PCR Technologies Market Breakdown, by Technology
- 10.1.1.6.2 Rest of Europe: Europe PCR Technologies Market Breakdown, by Offerings
- 10.1.1.6.3 Rest of Europe: Europe PCR Technologies Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe PCR Technologies Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Promega Corp
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 QIAGEN NV
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 bioMerieux SA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Bio-Rad Laboratories Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Becton Dickinson and Co
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Takara Bio Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Standard BioTools Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Agilent Technologies Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Ellume Ltd
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
14. Appendix
14.1 About Business Market Insights